Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026)
Retractable Technologies (RVP) posted Income from Continuing Operations of 4225170.0 for Q1 2026, down 79.94% on a QoQ basis from 2348090.0 in Q4 2025, and up 59.76% year-over-year from 2644648.15 in Q1 2025.
Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Retractable Technologies' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 4225170.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 59.76% year-over-year to 4225170.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6289684.0 (up 72.43% YoY) and the FY2025 annual result came in at 12565230.0, down 5.71% from the prior year.
- Income from Continuing Operations was 4225170.0 for Q1 2026 at Retractable Technologies, down from 2348090.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 7616455.0 in Q1 2022 and bottomed at 14164640.0 in Q2 2024.
- A 5-year average of 1800553.24 and a median of 1921989.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations surged 5269.2% — and 2025, when it slumped 2545.53%.
- Retractable Technologies' Income from Continuing Operations stood at 4281556.0 in 2022, then surged by 98.3% to 72946.0 in 2023, then jumped by 5269.2% to 3770722.0 in 2024, then plunged by 162.27% to 2348090.0 in 2025, then sank by 79.94% to 4225170.0 in 2026.
- Business Quant data shows RVP's Income from Continuing Operations at 4225170.0 in Q1 2026, 2348090.0 in Q4 2025, and 371047.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Retractable Technologies | 20.36 Mn | -15.26 Mn | -838,408.00 | -4.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.23 Mn |
| Dec 31, 2025 | -2.35 Mn |
| Sep 30, 2025 | 371,047.00 |
| Jun 30, 2025 | -87,471.00 |
| Mar 31, 2025 | -10.50 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -14.16 Mn |
| Mar 31, 2024 | 429,384.00 |
| Dec 31, 2023 | -72,946.00 |
| Sep 30, 2023 | -4.06 Mn |
| Jun 30, 2023 | -3.87 Mn |
| Mar 31, 2023 | 990,972.00 |
| Dec 31, 2022 | -4.28 Mn |
| Sep 30, 2022 | 5.39 Mn |
| Jun 30, 2022 | -3.64 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 11.69 Mn |
| Sep 30, 2021 | 6.52 Mn |
| Jun 30, 2021 | 10.66 Mn |